285 filings
Page 2 of 15
S-8
qx26zpvblm8srmnqpam
21 Dec 22
Registration of securities for employees
5:26pm
6-K
95qpdr
20 Dec 22
Current report (foreign)
5:15pm
6-K
ey2ev6wom3mw
20 Dec 22
IMV Announces Closing of US$9 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
2:19pm
6-K
ysdz1 lmj
20 Dec 22
Current report (foreign)
6:09am
SUPPL
xc91uyr
20 Dec 22
Supplemental materials (foreign)
6:02am
SUPPL
j9u17 lvz9k0xlq2v
19 Dec 22
Supplemental materials (foreign)
5:26pm
6-K
u7ezqrgx6e bdclpt
16 Dec 22
IMV Announces US$9 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
11:40am
6-K
uqj8h8l32u e9
15 Dec 22
IMV Inc. Announces Initial Data from the Ongoing Phase 2B VITALIZE Trial in Patients with r/r DLBCL
9:20am
6-K
hxtmrfi5uqc5n2veeomh
13 Dec 22
IMV Commences Trading on the TSX and Nasdaq Post-Reverse Stock Split
9:12am
6-K
9wql6 xjerjjt8uhimo
7 Dec 22
Report of Foreign Private Issuer for the Month of Decemberer, 2022
4:20pm
6-K
l8eu16mbu7mp0mi23c
25 Nov 22
IMV Receives Nasdaq Notification Regarding Market Value of Listed Securities
4:26pm
6-K
8n2ls5kmf syqwm67oz
16 Nov 22
IMV Inc. Announces Third Quarter 2022 Financial and Operational Results
1:00pm
6-K
5azth53k9h4
10 Nov 22
Report of Foreign Private Issuer for the Month of November, 2022
4:09pm
6-K
endm8sby
28 Oct 22
Notice of Special Meeting of Shareholders
4:41pm
6-K
aadhlbujefr
12 Oct 22
Report of Foreign Private Issuer for the Month of October, 2022
11:16am
6-K
ocy4veegs7lu8ywk6of
16 Sep 22
Form 51-102F3 Material Change Report
2:51pm
6-K
vrdbwj4 g6
15 Sep 22
IMV Inc. Announces Strategic Reorganization
1:48pm
6-K
d2t be8sbdp
1 Sep 22
IMV Inc. to Present at Two Investor Conferences in September
9:24am
6-K
1ri31yy7xafg3en cz
12 Aug 22
IMV Inc. Announces Second Quarter 2022 Financial and Operational Results
1:44pm
6-K
ut92s7tsj7vol24hs
11 Aug 22
Report of Foreign Private Issuer for the Month of August, 2022
7:13am